MARKET

DBVT

DBVT

Dbv Technologies S A
NASDAQ
19.99
-0.37
-1.82%
Opening 12:34 05/12 EDT
OPEN
20.72
PREV CLOSE
20.36
HIGH
20.86
LOW
19.96
VOLUME
73.54K
TURNOVER
--
52 WEEK HIGH
26.19
52 WEEK LOW
7.53
MARKET CAP
1.18B
P/E (TTM)
-3.7974
1D
5D
1M
3M
1Y
5Y
1D
Deep Track Biotechnology Master Fund discloses net short position in DBV Technologies
PUBT · 1d ago
Weekly Report: what happened at DBVT last week (0504-0508)?
Weekly Report · 1d ago
Deep Track Biotechnology Master Fund discloses net short position in DBV Technologies
PUBT · 6d ago
Y-Intercept (Hong Kong) reports net short position in DBV Technologies
PUBT · 6d ago
Kepler Capital Sticks to Their Buy Rating for DBV Technologies (0QAJ)
TipRanks · 6d ago
DBV Technologies grants CEO Daniel Tassé 1,740,000 performance share units tied to FDA milestones
PUBT · 6d ago
Y-Intercept (Hong Kong) discloses net short position in DBV Technologies shares
PUBT · 05/05 14:05
DBV Technologies Price Target Maintained With a $51.00/Share by Guggenheim
Dow Jones · 05/04 13:34
More
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Webull offers DBV Technologies SA - ADR stock information, including NASDAQ: DBVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBVT stock methods without spending real money on the virtual paper trading platform.